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Abstract
Natural killer (NK) cells contribute to the initial nonspecific response to viral infection, and viruses exhibit a range of sensitivities to NK cells in vivo.
We investigated the role of NK cells in infection of mice by mouse adenovirus type 1 (MAV-1) using antibody-mediated depletion and knockout mice.
MAV-1 causes encephalomyelitis and replicates to highest levels in brains. NKcell-depletedmice infectedwithMAV-1 showed brain viral loads 8–20 days
p.i. that were similar to wild-type control non-depleted mice. Mice genetically deficient for NK cells behaved similarly to wild-type control mice with
respect to brain viral loads and survival. We conclude that NK cells are not required to control virus replication in the brains of MAV-1-infected mice.
© 2007 Elsevier Inc. All rights reserved.Keywords: Adenovirus; Mouse adenovirus; Natural killer cell; NK cell; Immunodepletion; BrainIntroduction
Mouse adenovirus type 1 (MAV-1) infects monocytes and
endothelial cells throughout the animal (Charles et al., 1998; Kajon
et al., 1998;Moore et al., 2003). In acute infection, the highest viral
loads are found in the brain, spinal cord, and spleen, and the virus
causes encephalomyelitis (Guida et al., 1995; Kajon et al., 1998;
Kring et al., 1995; Smith et al., 1998). Adaptive immune responses
toMAV-1 infection have been investigated using immunodeficient
mice. T lymphocytes contribute to pathology during the acute
phase of MAV-1 infection, since T cell-deficient mice display
fewer signs of immunopathology than do control mice (Moore et
al., 2003). Mice deficient in α/β T cells succumb to MAV-1
infection 9–12 weeks after infection with high viral loads, either
becauseMAV-1 replication is not limited during the acute phase or
because T cells are needed to suppress persistent MAV-1 replica-
tion, or both. Mice deficient in B cells or B cell functions succumb
to lowdoseMAV-1 infection 6–9 days after infection (Moore et al.,
2004). These mice have high viral loads and disseminated
infections; early Tcell-independent IgM and neutralizing antibody
are critical for protection from disseminated MAV-1 infection.⁎ Corresponding author. Department of Microbiology and Immunology,
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doi:10.1016/j.virol.2007.11.018The role of innate immune response components in MAV-1
infection has not been well studied. NK cells are a key effector of
the innate response to viral infection, and two major functions of
NK cells are cytotoxicity and secretion of interferon (IFN)-γ
(reviewed in Biron and Sen, 2007). However, NK cells are not
required for defense against all viruses. For example, in in-
fections of mice, mouse cytomegalovirus is sensitive to NK cells
(Bukowski et al., 1984) while lymphocytic choriomeningitis
virus and murine gammaherpesvirus 68 are relatively resistant
(Usherwood et al., 2005; Welsh, 1986, 1978; Welsh and
Kiessling, 1980). Little is known about the importance of NK
cells in controlling adenovirus infections in their natural hosts.
The adenoviruses are species-specific, and human adenoviruses
do not complete the full virus replication cycle inmice (reviewed
in Ginsberg, 1999). Nonetheless, mice infected with high doses
of human adenovirus develop pneumonia and have been used to
evaluate early immune responses. NK cells are activated in
response to injection with adenovirus vectors with and without
transgenes in C57BL/6 mice, showing increased IFN-γ expres-
sion and cytotoxic killing (Ruzek et al., 2002). This response is
independent of viral gene expression but requires intact viral
particles. Mice depleted of their NK cells express transgenes
longer than nondepleted mice (Peng et al., 2001). There are
mouse strain differences in NK cell responses to infection with
human adenovirus vectors, with higher NK cell activation,
cytotoxicity, and IFN-γ production in BALB/c mice compared
to C57BL/6 mice (Peng et al., 2001). Mouse NK cell
Fig. 1. Effects of NK cell depletion on BALB/c mice. (A) Representative
example of flow cytometric confirmation of depletion. BALB/cAnNCr mice
were injected i.p. at days –1, 1, 3, 5, 7 relative to infection with 1.07 mg of anti-
asialo GM1 or rabbit γ-globulin as control antibody. Animals were given a dose
of 102 PFU of MAV-1 i.p. and euthanized at 8 days p.i. Splenocytes were
analyzed for individual mice, and dot plots for one representative mouse of each
treatment group are shown. Percentages of DX5+ TCRβ− cells are indicated in
the top left quadrants; values are the mean and standard deviation for all the mice
in each treatment group (n=3–4 per group). Mice were analyzed individually
for both NK cell depletion and brain viral titer. (B) Brain titers following NK cell
depletion and MAV-1 infection of BALB/cAnNCr mice 8 days p.i., assayed by
capture ELISA. Each bar represents the background-subtracted average of the
group, with standard deviation indicated. The MAV-1 control is an internal
standard run in each assay as a positive control for the ELISA. A and B are
representative examples of three depletion experiments of BALB/cAnNCr mice
that all had similar results.
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gene early region 1A is higher than for cells not expressing the
gene, indicating that there are also NK cell responses elicited by
adenoviral gene expression (Cook and Routes, 2005).
There is one report of the role of NK cells in MAV-1 infection.
MAV-1 infection of CB.17/scid and CB.17/scid/beige mice was
compared (Charles et al., 1998); beige−/− (Lyst−/−) mice are
deficient in NK and other cell activity (Roder and Duwe, 1979;
Saxena et al., 1982). The two strains of mice succumbed toMAV-1
infection with similar kinetics and were resistant to neurologic
disease (Charles et al., 1998). The results suggest that the presence
ofNKcell activity offered no survival advantage to the SCIDmice.
The role for B cell function (production of early antiviral IgM)
inMAV-1 infection overlaps the timewhen typical innate immune
responses occur (Moore et al., 2004), and could reduce the need
for an NK cell response. NK cell killing is regulated by a balance
of positive and negative signaling through activating and in-
hibitory cell receptors (reviewed in Biron and Sen, 2007; Lodoen
and Lanier, 2006). Net activation of NK cell killing can occur
when NK cells have received positive activation signaling greater
than inhibitory signaling. Reduced inhibitory signaling can occur
when NK cells encounter cells with low levels of major histo-
compatibility complex (MHC) class I antigens, which are ligands
for some NK cell inhibitory receptors. Many viruses have mech-
anisms to downregulate MHC class I, thus protecting them from
CD8+ T cell killing, but making them potentially susceptible to
NK cell killing. However, MAV-1 does not downregulate MHC
class I during infection (Kring and Spindler, 1996). This suggests
that the cytotoxic function of NK cells might not be necessary for
control of MAV-1 infection. On the other hand, SJL mice, which
are highly susceptible to MAV-1 infection (Spindler et al., 2001),
display a “low NK” phenotype, defined as low endogenous levels
of NK cell killing that increase only minimally upon poly-I:C
treatment (Kaminsky et al., 1983). Thus MAV-1 resistance may
depend on functional NK cell responses.
To examine more thoroughly whether NK cells are necessary
for control of MAV-1 infection, we infected mice that had
undergone antibody-mediated depletion of NK cells and mice
genetically deficient for NK cells. Depletion of NK cells in two
MAV-1-resistant mouse strains, C57BL/6 and BALB/c, with
anti-NK1.1 and anti-asialo GM1 antibodies, respectively, had
no effect on control of replication of MAV-1 in the brain at early
and late times post infection (p.i.). Mice genetically deficient in
NK cells or a combination of NK and T cells did not differ from
control mice in viral loads or survival. We conclude that NK
cells are not required for control of MAV-1 replication in brains
of resistant BALB/c and C57BL/6 mice.
Results
Effects of NK cell depletion on early replication of MAV-1 in
the brains of BALB/c and C57BL/6 mice
BALB/c mice were depleted of NK cells using anti-asialo
GM1 to examine the ability of depleted mice to control MAV-1
infection at early times post infection. This antibody depletes
NK cells and antigen-specific T cells when administered in vivo(Slifka et al., 2000). Mice were treated every 2 days with
intraperitoneal (i.p.) injections of anti-asialo GM1 or control
antibody; injections began 1 day before i.p. infection with 102
plaque-forming units (PFU) of MAV-1, a dose more than 2 log
units below the 50% lethal dose (LD50) for BALB/c mice
(Guida et al., 1995; Spindler et al., 2001). Eight days after
infection, splenocytes were analyzed by flow cytometry to
measure the level of NK cell depletion (Fig. 1). NK cells were
identified byDX5+ TCRβ− staining and therefore fall in the upper
left quadrant of the dot plots. In mock-infected mice treated with
control antibody, 2.75% of the splenocytes were DX5+ TCRβ−,
whereas in anti-asialo GM1 antibody-treated mice the DX5+
TCRβ− cells were reduced to 0.45%, indicating a significant
depletion of the NK cells. Upon MAV-1 infection alone we
Fig. 2. NK cell depletion and infection in C57BL/6NCr mice. (A) Rep-
resentative example of flow cytometric confirmation of depletion. C57BL/6NCr
mice were mock depleted using a γ-globulin control antibody (upper panels) or
were depleted of NK cells using PK136 (lower panels). On days –1 and 0
animals were injected i.p. with 100 μg of antibody. Intraperitoneal infection with
103 PFU of MAV-1 or mock infection also occurred on day 0. Splenocytes
isolated from mice 8 days p.i. were analyzed individually, and one mouse of
each treatment group is shown. Percentages of NK cells in the spleen are
indicated in the upper left quadrant (DX5+, TCRβ−) for the four treatment
groups; values are the mean and standard deviation for all the mice in each
treatment group (n=4–5 per group). Depletions were also confirmed by staining
for NK1.1 instead of DX5 (data not shown). (B) Viral loads in the brain were
determined by plaque assay for each animal, treated either with control γ-
globulin or PK136, as indicated. Serially diluted MAV-1 was concurrently
titrated as a positive control (data not shown). Results are one example of three
replicate experiments performed. (C) Viral loads were also determined for the
same animals as in B using capture ELISA. The MAV-1 control is an internal
standard run in each assay as a positive control for the ELISA.
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compare top panels), but because there were increased numbers of
total splenocytes in the infected mice, the absolute number of NK
cells did not differ between mock and infected control antibody-
treatedmice (data not shown). There was no significant difference
in percentage of NK cells between the antibody-depleted mock-
infected and antibody-depleted MAV-1-infected groups (Fig. 1A,
lower panels, 0.45% and 0.51%). We analyzed the brain viral
loads from all of the infected mice to determine the effects of NK
cell depletion on viral replication. The brain viral titers were
measured by enzyme linked immunosorbent assay (ELISA); there
were no significant differences between controlmice andNKcell-
depleted mice (Fig. 1B). There were also no clinical signs of
disease observed in infected NK cell-depleted or control mice.
The finding that NK cell depletion did not lead to increased viral
replication suggests that BALB/cmice do not require NK cells for
control of MAV-1 in the brain at early times after infection.
We tested the effect of NK cell depletion in C57BL/6 mice, a
strain in which NK cells can be depleted with the anti-NK1.1
antibody (PK136). Mice were treated with PK136 i.p. on days –1
and 0 and infected i.p. on day 0 with 103 PFU of MAV-1, a dose
more than 1.4 log units below the LD50 for C57BL/6 mice (Guida
et al., 1995; Spindler et al., 2001).Micewere euthanized on day 8,
and flow cytometric analysis of their splenocytes revealed that
treatment with PK136 effectively depleted NK cells while treat-
ment with control antibody had no effect (Fig. 2A). The upper left
quadrant of the dot plots indicates NK cells (DX5+ TCRβ−). The
upper plots illustrate that 3.30% of the splenocytes in mock-
depleted, mock-infected animals were DX5+ TCRβ−, whereas
the lower plots show that only 0.52% of splenocytes in PK136-
treated, mock-infected animals were NK1.1+ TCRβ−, indicating
a significant depletion of NK cells. The PK136 antibody also
depletes NK1.1 T cells (Mühlen et al., 2004), and a reduction in
this cell population can be seen in these experiments (upper right
quadrants of the dot plots). MAV-1 infection alone (in the absence
of NK cell depletion) of C57BL/6 mice resulted in a reduction in
the percentage of splenic NK cells (Fig. 2A, compare upper left
and right panels), but because of increased numbers of spleno-
cytes in the infected mice, the number of NK cells was similar
between mock- and virus-infected control antibody-treated mice
(data not shown). Brain titers of NK cell-depleted and mock-
depleted animals were measured by plaque assay and capture
ELISA; we have previously shown that ELISA and plaque assay
measurements of viral load correlate (Welton et al., 2005). A
similar correlation is seen here (Fig. 2B, C). There were no
significant differences in viral load between NK cell-depleted
mice and mock-depleted mice (Fig. 2B, P=0.12; Fig. 2C,
P=0.46). There were also no observable clinical signs of disease
in infected NK-cell depleted or control mice. These results
indicate that the absence of NK and NK1.1 T cells did not alter
viral replication in the brains of C57BL/6 mice at early times after
MAV-1 infection.
To examine the role of NK cells at other times in infection,
we depleted C57BL/6 mice of their NK cells for 4, 14 or
20 days. Mice were injected with either PK136 or a control
antibody on days –1, 0, 7, 8, 15 and 16 and infected with 103
PFU of MAV-1 on day 0. At 4 days p.i. in infected NK cell-depleted and mock-depleted mice, brain viral loads were below
the limit of detection (data not shown). At 14 or 20 days p.i.,
groups of mice were euthanized, and the effectiveness of the NK
cell depletion was examined by flow cytometry of splenocytes.
NK cells were depleted in mice treated with PK136 at both 14
and 20 days p.i. (Fig. 3A and data not shown). NK cells
comprised 2–4% of the splenocytes in control antibody-treated
mice but b0.9% of splenocytes in PK136-treated mice. This
indicates that the long-term treatment schedule effectively
depleted NK cells. Although there was a lower percentage of
NK cells in virus-infected γ-globulin-treated mice compared to
mock-infected mice (compare Fig. 3A upper left and right
Fig. 3. Effect of NK cell depletion and infection in C57BL/6NCr mice at
14–20 dpi. (A) Mice were given γ-globulin or PK136 on days –1, 0, 6 and 7
for 14-day infections and on days –1, 0, 6, 7, 13 and 14 for 20-day infections. Mice
were infected i.p. with 103 PFU of MAV-1 on day 0. NK cell depletion was
confirmed by flow cytometry as shown in this representative example from
14 days p.i. in which one mouse of each treatment group is shown. Percentages of
NK cells in the spleen are indicated in the upper left quadrant (DX5+, TCRβ−)
for each of the four groups; values are the mean and standard deviation for all
the mice in each group (n=3). For the 20-day samples the depletions were
comparable (data not shown). Depletions were also confirmed by staining for
NK1.1 instead of DX5 (data not shown). (B) Viral loads in the brain as determined
by plaque assay in mock depleted (circles) or NK cell-depleted (squares) mice 14 or
20 days p.i. Dotted line indicates the limit of reliable detection in the plaque
assay (2×103 PFU/g).
Fig. 4. Capture ELISA quantitation of brain viral titers in MAV-1-infected
C57BL/6NTac (control) and IL-15 −/− mice. Animals were infected for 8 days
with 102 PFU of MAV-1. Each bar represents the background subtracted aver-
ages per group; n=5 for each group. The MAV-1 control is an internal standard
run in each assay as a positive control.
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more splenocytes in the infected mice (data not shown). At
14 days p.i., NK cell-depleted mice had a low level of detectable
virus in their brains, whereas mice that were mock-depleted had
viral loads that were below the limit of reliable detection by
plaque assay (Fig. 3B). This suggests that there may have been a
slower rate of clearance of virus in the absence of NK cells.
However, by 20 days p.i., mice in both the NK cell-depleted and
control groups had cleared MAV-1, with brain viral titers below
the limit of reliable detection by plaque assay, indicating that the
overall result was clearance of the virus in both the absence and
presence of NK cells. No clinical signs of disease were observed
for NK cell-depleted or control mice at any time point. Despite the
difference in viral load at 14 days p.i. between the mock- and NKcell-depleted mice, the ability of all animals to control the
infection by day 20 is consistent with results described above that
NK and NK1.1 T cells were not required for the control of acute
MAV-1 infection.
Virus loads in MAV-1 infected IL-15−/− mice are similar to those
in control mice
To test if mice genetically deficient in NK cells retain the
ability to control MAV-1 at early times post infection, we tested
interleukin (IL)-15−/− (C57BL/6NTac-IL15tm1Imx) mice, which
lack NK cells and also have reductions in memory CD8 T cells,
NK1.1 T cells and Thy1− CD8α intraepithelial lymphocytes
(Kennedy et al., 2000). IL-15−/− and control C57BL/6NTac
mice were infected i.p. with 102 PFU of MAV-1 and euthanized
8 days p.i. Brain viral titers were analyzed by capture ELISA.
IL-15−/− mice did not show increased viral titers compared to
the control mice (Fig. 4). Neither NK cell-deficient nor control
mice showed any signs of clinical disease. This result suggests
that IL-15, NK cells, memory CD8 T cells, NK1.1 T cells and
Thy1− CD8α intraepithelial lymphocytes were not required to
control MAV-1 infection. These data are consistent with the data
in Figs. 1–3 that neither NK cells nor NK1.1 T cells played a
major role in the control of MAV-1 infection in the brain.
Effects of the combined lack of NK cells and T cells on
replication of MAV-1 in the brains of CD3εtg mice
We further tested the importance of NK cells using a strain of
mice lacking both NK and T cells. T cell-deficient mice are able
to control MAV-1 infection at early times but succumb 10–
12 weeks p.i. (Moore et al., 2003). CD3εtg mice lack NK cells
and T cells (Wang et al., 1994) and provide another genetically
deficient model in which to test the importance of NK cells for
control of MAV-1 at early and late times of infection, albeit in
the background of T cell deficiency. CD3εtg and C57BL/6
control mice were infected i.p. with 102 PFU of MAV-1 and
euthanized 8 days p.i. Brain viral titers were analyzed by plaque
assay. Titers were similar for both C57BL/6 and CD3εtg in-
fected mice (Fig. 5), indicating that CD3εtg mice did not differ
from C57BL/6 controls in their ability to control MAV-1
infection at 8 days p.i. Mice were also analyzed at 4 and 6 days
p.i. Viral loads were below the limit of detection in both CD3εtg
and C57BL/6 mice at 4 days p.i., but at 6 days p.i. viral loads
Fig. 5. Infection of CD3εtg and C57BL/6NCr mice. Animals were infected for
8 days with 102 PFU of MAV-1. Viral loads in the brain were determined by
plaque assay and were not significantly different (P=0.76).
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(data not shown). To examine a role for NK cells in long-term
MAV-1 infections, CD3εtg mice (deficient in NK and T cells)
were compared to B6.129P2-Tcrbtm1Mom Tcrdtm1Mom/J (βxδ)
mice (deficient in αβ and γδ T cells). These two strains and
C57BL/6 control mice were infected with 102 PFU of MAV-1,
and survival was measured over the course of 10 weeks. The
results indicate there was not a significant difference in the
ability to control MAV-1 infection in mice lacking NK and T
cells compared to mice lacking only T cells (Supplementary
Figure). These data are consistent with the findings above that
NK cells were not critical for control of MAV-1 infection of
BALB/c and C57BL/6 mice.
Discussion
We hypothesized that NK cells may be important for MAV-1
infection because SJL mice, which are susceptible to MAV-1
(Spindler et al., 2001), have a “low NK” phenotype (Kaminsky
et al., 1983). That is, they have low endogenous levels of NK
cell activity that are not increased by treatment with IFN-γ or
IFN inducers. The corollary is that NK cells of MAV-1-resistant
mouse strains contribute to this resistance to infection. To test
this, we depleted resistant mouse strains of their NK cells in
order to mimic the low NK phenotype of SJL mice. BALB/c
mice are considered to be resistant to MAV-1 and C57BL/6
mice are relatively resistant, with a 1–2 log unit lower LD50
than BALB/c (Guida et al., 1995; Spindler et al., 2001). Despite
this lower LD50, C57BL/6 mice are able to survive and clear
virus doses used in these experiments (Moore et al., 2003,
2004). In the experiments reported here, mice of these two
inbred strains were efficiently depleted of NK cells by
administration of anti-asialo GM1 antibody (BALB/c) or anti-
NK1.1 antibody (C57BL/6). Mice depleted of NK cells by
antibody injection showed no clinical signs of disease, and brain
viral loads were similar in NK cell-depleted and mock-depleted
mice 8–20 days post infection (Figs. 1–3). These results in-
dicate that a lack of NK cells did not result in altered levels of
MAV-1 replication in the brain in the acute phase of infection
and suggest that NK cell depletions did not increase the ability
of MAV-1 to traffic to the brain. The data do not support the
hypothesis that MAV-1-susceptible mouse strains are suscep-
tible because of functional NK cell deficiency.
The antibody depletion strategies used in these studies
deplete NK1.1 T cells as well as the larger NK cell population.IL-15−/− mice also lack NK1.1 T cells, allowing for the pos-
sibility that an absence of this cell population played a role in
these results. While not yet fully understood, the role of NK1.1
T cells in fighting infection is believed to occur primarily
through their rapid release of IFN-γ and ability to activate other
immune cells (Van Dommelen and Degli-Esposti, 2004). NK1.1
T cells have been reported to confer protection or partial pro-
tection from various viral and bacterial infections including
HSV-1 and HSV-2 (Ashkar and Rosenthal, 2003; Grubor-Bauk
et al., 2003) and Streptococcus pneumoniae (Kawakami et al.,
2003). The simultaneous depletion of NK and NK1.1 T cells
had no effect on pathogenesis or brain viral loads in MAV-1-
infected mice. Given these results we conclude that NK1.1 T
cells are unlikely to play a role in controlling MAV-1 infection.
Depletions of NK cells by anti-asialo GM1 and PK136
antibody treatment have been widely demonstrated to function-
ally deplete NK cell activity in vivo (Wang et al., 1998; Welsh et
al., 1990). Furthermore, use of mice genetically deficient for
NK cells confirmed the results obtained by NK cell-depletion,
i.e., lack of NK cells did not make BALB/c or C57BL/6 mice
more susceptible to MAV-1 infection in the brain. IL-15 induces
the activation and increases the cytotoxicity of mature NK cells,
and it is crucial for NK cell development and maintenance of
memory CD8+ T cells (Carson et al., 1994; Goldrath et al.,
2002; Kennedy et al., 2000; reviewed in Prlic et al., 2002). Due
to these roles, mice deficient in IL-15 lack NK cells and have
reductions in memory CD8+ T cells, NK1.1 T cells and Thy1−
CD8α intraepithelial lymphocytes (Kennedy et al., 2000).
Despite these defects, IL-15−/− mice mount effective virus-
specific primary CD8+ T cell responses and control some ex-
perimental viral infections (Becker et al., 2002; Goldrath et al.,
2002; Obar et al., 2004; Zuo et al., 2005) but not others
(Kennedy et al., 2000; Schluns et al., 2002). We found that IL-
15−/− mice showed no increase in susceptibility to MAV-1 upon
infection relative to control mice on the same strain background.
These data support our findings that NK cells are not required
for control of MAV-1 infection. Furthermore they indicate that
IL-15, memory CD8+ T cells, NK1.1 T cells and Thy1− CD8α
intraepithelial lymphocytes also do not play a significant role in
the acute phase of infection.
CD3εtg mice are another genetically NK cell-deficient mouse
model. These mice are deficient in T cells and NK cells and
showed no differences in MAV-1 brain viral titers from control
mice at 6 and 8 days p.i. We compared long-term survival of
these CD3εtg mice that lack both NK and T cells to mice that
lack only T cells (βxδ) (Supplementary Figure). Previous work
using T cell-deficient mice (βxδ and others) showed that T cells
are required for long-term control of viral infection (Moore et al.,
2003). In the experiments reported here, CD3εtg mice suc-
cumbed to MAV-1 infection before all of the βxδ mice,
suggesting that the NK cell deficiency in the CD3εtg mice
may have an effect on long-term survival. However, statistical
analysis revealed that the difference was not significant at the 5%
level. We note that the genetic cause of the T cell deficiency is
different in the βxδ and CD3εtg mice, and that there are in-
evitable minor strain background differences arising from
backcrossing the T cell mutations to the C57BL/6J background.
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two Tcell deficiencies. However, the long-term survival data for
the CD3εtg mice are consistent with only a modest role (if any)
for NK cells late in MAV-1 infection. Our data suggest that the
role of T cells in controlling MAV-1 infection is greater than that
of NK cells.
Althoughwewere initially surprised that a lack of NK cells did
not alter disease signs, survival, and brain viral loads in MAV-1
infection, our data are consistent with the results of Charles et al.
(1998), who examined MAV-1 infection of mice carrying a mu-
tation of the Lyst (beige) gene. Lyst−/− mice (knocked out for the
lysosomal trafficking regulator) have reduced NK cell activity
(Roder and Duwe, 1979; Saxena et al., 1982). However these
mice do not lack all NK cell function, particularly in viral in-
fections (Kärre et al., 1980; Roder and Duwe, 1979; Welsh and
Kiessling, 1980). In addition, Lyst−/− mice have granulocyte
defects (Gallin et al., 1974); thus NK cells are not the only cells
affected. Charles et al. (1998) found that whether mice carried the
Lyst−/− mutation or not, they were equally susceptible to MAV-1
infection at lethal doses and lacked neurologic dissemination and
signs of central nervous system hemorrhage. Despite the caveats
about the pleiotropic effects of the Lyst−/− gene mutation, the data
suggest that the NK cell defects (and other defects) of the Lyst−/−
mice do not make mice more susceptible to MAV-1 infection.
In addition, in agreement with our findings for MAV-1,
there are other viruses known to be relatively resistant in vivo to
the effects of NK cells. These include lymphocytic choriome-
ningitis virus and murine gammaherpesvirus 68 (Usherwood
et al., 2005; Welsh, 1986, 1978; Welsh and Kiessling, 1980).
We consider here reasons why control of MAV-1 replication in
the brain is not dependent on NK cells. Alteration of MHC
class I expression is a common tactic viruses employ to evade
detection and activation by immune cells (Orange et al., 2002).
The balance of NK cell activation vs. inhibition can be shifted
toward activation of cytotoxicity when NK cells detect target
cells expressing reduced levels of MHC class I (reviewed in
Biron and Sen, 2007). A previous finding suggests that NK cell
recognition of “lowMHC class I” cells may not be important for
control of MAV-1 infection: MAV-1 infection does not decrease
MHC class I expression (Kring and Spindler, 1996). This may
reduce the need for NK cell-mediated cytolysis of cells lacking
MHC class I. NK cells in mice deficient for MHC class I are
defective in target killing (Yokoyama and Kim, 2006). Mice
genetically deficient for MHC class I expression (β2m−/−)
survive infection with MAV-1 and are able to clear virus nearly
as well as control mice (Moore et al., 2003), despite having
functionally defective NK cells. Another reason why NK cells
may not be critical for response to MAV-1 infection is that they
may not be needed for production of IFN-γ. Antigen-presenting
cells produce large amounts of IFN-γ in response to IL-12, and
the amounts of IFN-γ produced in vitro by dendritic cells and
macrophages are substantially larger than those produced by
NK cells (Fukao and Koyasu, 2000; Fukao et al., 2000; Ohteki
et al., 1999; Puddu et al., 1997). MAV-1 infection induces
transient IL-12 expression in splenocytes and peritoneal cells,
which should thus induce IFN-γ (Coutelier et al., 1995). IFN-γ
likely plays a role in control of MAV-1 infection, because micedeficient for IFN-γ are more susceptible than control mice to
MAV-1 infection (M. Moore and K. Spindler, unpublished).
However we postulate that T cells and antigen presenting cells
produce enough IFN-γ to control the MAV-1 infection in the
absence of NK cells.
The data presented in this report indicate that NK cells are not
required for control ofMAV-1 infection at early or late times post
infection, as measured by brain viral loads. This suggests that
neither cytotoxic effects nor IFN-γ secretory functions of NK
cells are critical to the control of MAV-1 replication. These
studies also suggest that the “low NK” phenotype of MAV-1-
susceptible SJL mice is not responsible for their inability to
control MAV-1 replication. This is consistent with our suscept-
ibility mapping studies (Welton et al., 2005), which indicate
that a major quantitative trait locus on mouse Chromosome 15
is involved in susceptibility to MAV-1, whereas we found no
quantitative trait loci for susceptibility on Chromosome 6, where
the mouse natural killer complex locus maps. Combined, these
data indicate that in mouse strains with a range of susceptibilities
to MAV-1 infection, NK and NKT cells are unimportant for
control of replication of virus in the brain.
Materials and methods
Mice, virus, infections, and statistics
BALB/cAnNCr and C57BL/6NCr mice were obtained from
the National Cancer Institute (Bethesda, MD). CD3εtg mice were
a kind gift of E. Szomolanyi-Tsuda. These mice express human
CD3ε in high copy and are defective in T cells and NK cells, but
not B cells (Hollander et al., 1995; Szomolanyi-Tsuda et al., 2001;
Wang et al., 1994). These mice had been backcrossed onto a
C57BL/6 background for 10 generations by Dr. Szomolanyi-
Tsuda. C57BL/6NTac-IL15tm1Imx mice and C57BL/6NTac back-
ground controls were obtained from Taconic (Germantown, NY),
originally generated in the laboratory of Dr. Jacques Peschon of
the Immunex Corporation (Seattle, WA). IL-15−/− mice lack NK
cells and have reductions in memory CD8 T cells, NK1.1 T cells
and Thy1− CD8α intraepithelial lymphocytes (Kennedy et al.,
2000). C57BL/6NCR.129P2-Tcrbtm1Mom Tcrdtm1Mom/J (βxδ)
were obtained from The Jackson Laboratory (Bar Harbor, ME).
These mice had been backcrossed onto a C57BL/6 background
for an unknown number of generations, and C57BL/6NCr mice
were used as background controls. Theseβxδmice do not express
αβ T-cell receptor or any γδ T-cell receptor and are thus deficient
in both αβ and γδ T lymphocytes.
Mice were infected i.p. with 102 or 103 PFU of MAV-1 in
100 μl phosphate-buffered saline or mock-infected with
conditioned media (media from uninfected cells 3–5 days
post confluence) similarly diluted. Mice were euthanized by
CO2 asphyxiation at 8, 14 or 20 days p.i. or when moribund in
the long-term survival experiment and their organs were
harvested. All mice were maintained in microisolator housing
with food and water ad libitum. All animal work complied with
relevant federal and institutional policies. MAV-1 was grown
and titrated in NIH 3T6 cells, a mouse fibroblast cell line
(Cauthen et al., 2007).
169A.R. Welton et al. / Virology 373 (2008) 163–170A log rank (Mantel-Cox) test of the null hypothesis that the
survival curves (based on Kaplan–Meier estimates) were
equivalent was performed using SPSS software. Student's t
test analyses were performed using Microsoft Excel.
Depletion of NK cells
To deplete NK cells in BALB/cAnNCr mice, 1.07 mg anti-
asialo GM1 antibody (Wako Chemicals USA, Inc., Richmond,
VA) was administered i.p. on days –1, 1, 3, 5, 7 relative to
infection (day 0). Control animals were given the same dose of
rabbit γ-globulin (Jackson ImmunoResearch Laboratories, Inc.,
West Grove, PA). To deplete NK cells in C57BL/6NCr mice, an i.
p. injection of 100 μg of PK136, a rat monoclonal against mouse
NK1.1 antigen (purified by University of Virginia Lymphocyte
Culture Center), was administered on days –1 and 0 relative to
infection (day 0) for a total dose of 200 μg. The same dose of rat
IgG antibody (Jackson ImmunoResearch Laboratories, Inc., West
Grove, PA) was given to control mice. For long-term NK cell
depletion inC57BL/6NCrmice, animals were given 100μg doses
of PK136 on days –1, 0, 7, 8, 15 and 16 relative to infection. NK
cell depletion was confirmed by flow cytometry in every ex-
periment. Depletion with PK136 and anti-asialo GM1 antibody
reduced NK cell numbers to a mean of 6 or 16% of non-depleted
levels of NK cells, respectively.
Flow cytometry analysis
C57BL/6NCr splenocytes were stained with antibodies to
NK1.1, TCRβ andDX5 (BDBiosciences, San Jose, CA). BALB/
cAnNCr splenocytes were stained with antibodies to TCRβ and
DX5 (BD Biosciences, San Jose, CA). Analysis was conducted
on 150,000 cells per sample in C57BL/6NCr experiments and
200,000 cells per sample in BALB/cAnNCr experiments. Stained
samples were analyzed by flow cytometry with a FACScan™ or
FACSCaliber flow cytometer and CellQuest™ (BD Biosciences,
San Jose, CA) or FlowJo (Tree Start Inc, Ashland, OR) software.
Efficient NK cell depletion was confirmed by identifying NK
cells as NK1.1+TCRβ− and DX5+ TCRβ− in the case of C57BL/
6NCr mice or DX5+ TCRβ− in the case of BALB/cAnNCr mice.
Quantitation of virus
Brain homogenates were prepared using the Mini-Beadbeater-
96 (BioSpec Products, Bartlesville, OK) as previously described
(Welton et al., 2005; Welton and Spindler, 2007). Briefly, the
∼100 mg samples were mechanically disrupted with sterile glass
beads in phosphate-buffered saline and assayed via plaque assay
(Cauthen et al., 2007) or by antigen capture ELISA (Welton et al.,
2005; Welton and Spindler, 2007). These two methods of virus
quantitation have been shown by regression analysis to have a
high correlation coefficient (Welton et al., 2005).
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